Ritalin (methylphenidate hydrochloride) is one of the most widely prescribed and longest-established medications for attention deficit hyperactivity disorder (ADHD) and narcolepsy worldwide. First approved in the United States in 1955, it remains a first-line pharmacological treatment in clinical guidelines across the United States, United Kingdom, Germany, Canada, Australia, France, the Netherlands, Switzerland, Finland, Austria, Japan, […]
In 2026, Ritalin (methylphenidate hydrochloride) continues as one of the most prescribed stimulant medications for attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults, as well as for narcolepsy in certain cases. Available in immediate-release tablets (typically 5mg, 10mg, 20mg) and extended-release formulations, Ritalin increases dopamine and norepinephrine availability in the brain, improving attention, […]